It is a pharma private limited company based in Kamothe, Maharashtra, India, established in 2017.
2017 | Kamothe, Maharashtra, India | ActiveBrillanz Pharma Private Limited, a active private limited company, was established on 08 February 2017 in Kamothe, Maharashtra, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U74999MH2017PTC290928. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Prannoti Hemant Mote (Director), Deepali Manoj Tarate (Director). Its latest AGM occurred on 28 September 2023, with the balance sheet filed on 31 March 2023. It is based at Fl-D/303,Satyakunj Com, Plot No.41&42,Sector-3,, Kamothe, Maharashtra, 410209.
U74999MH2017PTC290928
290928
08 February 2017
₹0.50 M
₹0.10 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Brillanz Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Prannoti Hemant Mote | Director | 08 Feb 2017 | Current |
| Deepali Manoj Tarate | Director | 08 Feb 2017 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Brillanz Pharma Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 529.78% increase. The company also saw a substantial improvement in profitability, with a 45.15% increase in profit. The company's net worth observed a substantial decline by a decrease of 15.35%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2018, Brillanz Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Brillanz Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Brillanz Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Brillanz Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Brillanz Pharma Private Limited last Annual general meeting of members was held on 28 Sep 2023 as per latest MCA records. was recorded as a recent event.
The activity Brillanz Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Mumbai. was completed.
Progress on Prannoti Hemant Mote was appointed as a Director was appointed as a Director on 08 Feb 2017 & has been associated with this company since 8 years 10 months . was documented.
The activity Deepali Manoj Tarate was appointed as a Director was appointed as a Director on 08 Feb 2017 & has been associated with this company since 8 years 10 months . was completed.
The activity Brillanz Pharma Private Limited was registered on 08 Feb 2017 with Roc Mumbai & aged 8 years 10 months as per MCA records. was completed.
The CIN of Brillanz Pharma Private Limited is U74999MH2017PTC290928.
Brillanz Pharma Private Limited is headquartered at Fl-D/303,Satyakunj Com, Plot No.41&42,Sector-3,, Kamothe, Maharashtra, 410209.
Brillanz Pharma Private Limited was incorporated on 08 February 2017.
The current directors of Brillanz Pharma Private Limited are
The primary industry of Brillanz Pharma Private Limited is Pharma.
Brillanz Pharma Private Limited is unlisted.
The authorized capital of Brillanz Pharma Private Limited is ₹0.50 M, and the paid-up capital is ₹0.10 M.
The compliance status of Brillanz Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX